BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:AnaCardio AB readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of studies AnaCardio AB's drugs run\, from C
 linicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07584967-663@assetmemo.bio
DTSTAMP:20261121T005708Z
DTSTART;VALUE=DATE:20280730
DTEND;VALUE=DATE:20280731
SUMMARY:AC01: Phase 2 readout est. (NCT07584967)
DESCRIPTION:AC01\, phase 2\, Heart Failure.\nStudy: A Study to Evaluate the
  Safety and Efficacy of AC01 Compared to Placebo in Participants With Chro
 nic Heart Failure\nEstimated primary completion: 30 July 2028. This is a C
 linicalTrials.gov estimate\, not a confirmed readout date\, and it can mov
 e.\nDrug page: https://assetmemo.bio/drug/ac01#upcoming-events\nRegistry r
 ecord: https://clinicaltrials.gov/study/NCT07584967
URL:https://assetmemo.bio/drug/ac01#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
